KR920005746B1 - Process for the preparation of oxazino benzothiazine 6,6-dioxide derivatives - Google Patents

Process for the preparation of oxazino benzothiazine 6,6-dioxide derivatives Download PDF

Info

Publication number
KR920005746B1
KR920005746B1 KR1019900003775A KR900003775A KR920005746B1 KR 920005746 B1 KR920005746 B1 KR 920005746B1 KR 1019900003775 A KR1019900003775 A KR 1019900003775A KR 900003775 A KR900003775 A KR 900003775A KR 920005746 B1 KR920005746 B1 KR 920005746B1
Authority
KR
South Korea
Prior art keywords
formula
carbonate
compound
benzothiazine
reaction
Prior art date
Application number
KR1019900003775A
Other languages
Korean (ko)
Other versions
KR910016763A (en
Inventor
이병석
유동식
Original Assignee
일동제약 주식회사
이금기
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 일동제약 주식회사, 이금기 filed Critical 일동제약 주식회사
Priority to KR1019900003775A priority Critical patent/KR920005746B1/en
Publication of KR910016763A publication Critical patent/KR910016763A/en
Application granted granted Critical
Publication of KR920005746B1 publication Critical patent/KR920005746B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A method for preparing oxazino benzothiazine 6,6-dioxide derivs. of formula (I) comprises (a) reacting a cpd. of formula (II) with bis(trihalomethyl)carbonate of formula (Hal)3COCOOC(Hal)3 in an inert organic solvent, and (b) reacting the mixture with 2-amino pyridine in the presence of an acid bonding agent. In (II), X=OH or halogen. The inert solvent is selected from dichloromethane, chloroform, tetrahydro furane, dioxane or benzene. The acid bonding agent is selected from Na2CO3, K2CO3, NaHCO3, KHCO3, triethylamine or pyridine. The cpds. (I) are useful as a prodrug of piroxicam (nonsteroidal antiphlogistic).

Description

옥사지노벤조티아진 6,6-디옥사이드 유도체의 제조방법Method for preparing oxazinobenzothiazine 6,6-dioxide derivative

본 발명은 비스테로이드성 소염제 및 진통제인 구조식(Ⅱ)로 표시도는 피록시캄으로부터 유도되는 프로드럭(Prodrug)인 다음 구조식(Ⅰ)의 5-메틸-3-(2-피리딜)-2H,5H-1,3-옥사지노-[5,6-c]1,2-벤조티아진-2,4(3H)-디온 6,6-디옥사이드의 새로운 제조방법에 관한 것이다.The present invention relates to 5-methyl-3- (2-pyridyl) -2H of the following structural formula (I) which is a prodrug derived from pyroxicam, which is a nonsteroidal anti-inflammatory and analgesic agent. A novel process for preparing, 5H-1,3-oxazino- [5,6-c] 1,2-benzothiazine-2,4 (3H) -dione 6,6-dioxide.

Figure kpo00001
Figure kpo00001

소염진통 효과가 탁월한 피록캄의 유용성 및 제조방법은 미합중국 특허 제3,591,584호등에 기술되어 있다. 특히 본 발명의 목적화합물인 구조식(Ⅰ) 화합물의 유용성과 제조방법은 대한민국 특허 공고 제87-627호, 미합중국 특허 제 4,563,452호 및 유럽특허 제242289호에 기술되어 있으며, 본 발명의 구조식(Ⅰ) 화합물은 엔올성 산인 피록시캄과 비교하여 감소된 위장장애를 나타낸다고 보고되어 있다.The usefulness and preparation of pyroxam with excellent anti-inflammatory analgesic effects are described in US Pat. No. 3,591,584. In particular, the usefulness and preparation method of the compound of formula (I), which is the target compound of the present invention, are described in Korean Patent Publication No. 87-627, US Patent No. 4,563,452, and European Patent No. 242289, and the structural formula (I) of the present invention. The compound is reported to exhibit reduced gastrointestinal upset compared to the enolic acid, pyroxicam.

지금까지 알려진 구조식(Ⅰ) 화합물의 제조 방법은 미합중국 특허 제 4,563,452호, 대한민국 특허 공고 제87-627호, 유럽특허 제242289호등에 기술되어 있으며, 이들 제조 방법들은 다음과 같이 요약될 수 있다.Known methods for preparing the compound of formula (I) are described in US Pat. No. 4,563,452, Korean Patent Publication No. 87-627, European Patent No. 242289, and the like. These preparation methods can be summarized as follows.

1. 다음 일반식(Ⅲ) 화합물과 우레탄 유도체인 구조식(Ⅳ) 화합물을 고온 감압하에 용융 반응시켜 구조식(Ⅰ) 화합물을 얻는 방법(미합중국 특허 제4,563,452호)1.Method of obtaining the compound of the formula (I) by melt-reacting the following compound of the general formula (III) and the compound of the urethane derivative under high temperature and reduced pressure (US Pat. No. 4,563,452)

Figure kpo00002
Figure kpo00002

상기식에서 R은 선형 또는 사슬형의 저급 C1-C4알킬기이다.Wherein R is a linear or chained lower C 1 -C 4 alkyl group.

2. 다음 구조식(Ⅱ)로 표시되는 피록시캄에 포스겐이나 에틸크로로포메이트를 반응시켜 구조식(Ⅰ)의 화합물을 제조하는 방법.(대한민국 특허공고 제87-627호, 유럽특허 제242289호)2. A method for preparing the compound of formula (I) by reacting phosgene or ethyl chloroformate represented by the following formula (II). (Korean Patent Publication No. 87-627, European Patent No. 242289) )

Figure kpo00003
Figure kpo00003

상기식에서 R1은 C1-C4알콕시, 펜옥시, 벤질옥시, 트리클로로메톡시(특히 염소)이다. 그러나 상기 미합중국 특허 제4,563,452호에 기술된 방법은 질소기류중에서 고온하에 용융반응을 시켜야 할 뿐만 아니라 반응중 생성되는 페놀을 25mmHg에서 감압증류하여야 반응이 되는 불편이 되는 수율도 68%로 저조하다. 또한 대한민국 특허공고 제87-627호(수율56%) 및 유럽특허 제242289호에 기술된 방법은 출발물질이 고가인 피록시캄을 출발로 하여 비경제적일 뿐만 아니라 맹독하기 때문에 다루기가 매우 힘든 포스겐을 사용하는 번거로움이 있다.Wherein R 1 is C 1 -C 4 alkoxy, phenoxy, benzyloxy, trichloromethoxy (particularly chlorine). However, the method described in U.S. Patent No. 4,563,452 not only has to melt at high temperature in a stream of nitrogen but also yields an uncomfortable yield of 68% when the phenol produced during the reaction is distilled under reduced pressure at 25 mmHg. In addition, the method described in Korean Patent Publication No. 87-627 (56% yield) and European Patent No. 242289 has a phosgene that is difficult to handle because it is not only economical but also toxic because the starting material is expensive pyroxycam. There is a hassle to use.

본 발명은 상기의 방법들과는 달리 구조식(Ⅵ) 화합물을 구조식(Ⅶ)의 비스(트리할로메틸) 카르보네이트와 반응시킴을 특징으로 하는 것이며, 이때 반응에서 생성되는 할로겐화 및 할로포밀화 되어진 구조식(Ⅷ) 화합물과 같은 중간체는 분리하지 않고 계속해서 구조식(Ⅴ)의 2-아미노 피리딘과 반응시켜 목적하는 구조식(Ⅰ) 화합물을 높은 수율로 제조할 수 있는 새로운 방법에 관한 것이다.Unlike the above methods, the present invention is characterized in that the compound of formula (VI) is reacted with bis (trihalomethyl) carbonate of formula (VII), wherein the halogenated and haloformylated structures generated in the reaction are produced. An intermediate, such as (iii), is a novel process which can be produced in high yield by the reaction of 2-amino pyridine of formula (V) without separation.

본 발명을 반응식으로 표시하면 다음과 같다.When the present invention is represented by the reaction scheme as follows.

Figure kpo00004
Figure kpo00004

Figure kpo00005
Figure kpo00005

상기식에서 X는 OH 또는 할로겐이며, Hal은 할로겐 원자이다.Wherein X is OH or halogen and Hal is a halogen atom.

또한 구조식(Ⅷ)로 표시되는 중간체는 X가 OH인 하기 구조식(Ⅵ) 화합물에 티오닐클로라이드와 같은 할로겐화 시약을 반응시킨 후 계속해서 구조식(Ⅶ)의 비스(트리할로메틸)카르보네이트를 반응시킴으로서 구조식 (Ⅷ) 화합물을 생성시켜 다음 반응에 분리하지 않고 사용할 수도 있다.In addition, the intermediate represented by Structural Formula (VIII) reacts a bis (trihalomethyl) carbonate of Structural Formula (VIII) after reacting a halogenating reagent such as thionyl chloride to the following Structural Formula (VI) wherein X is OH. By reacting, the compound of formula (VII) may be produced and used without separation in the next reaction.

Figure kpo00006
Figure kpo00006

식중 X 및 Hal은 전술한 바와 같다.Wherein X and Hal are as described above.

상기의 반응에 사용되는 구조식(Ⅶ)의 화합물중의 하나인 비스(트리클로로메틸)카르보네이트는 백색의 결정(융점 81-83℃)으로 안전한 시약으로서 취급하기가 매우 쉬울 뿐 아니라 운반, 저장이 용이하다. 또한 정확한 양을 쉽게 평량하여 화학반응에 사용할 수 있는 편리한 시약이다.Bis (trichloromethyl) carbonate, one of the compounds of formula (III) used in the above reaction, is a white crystal (melting point 81-83 ° C), which is not only easy to handle as a safe reagent, but also transported and stored. This is easy. It is also a convenient reagent that can be used in chemical reactions by easily weighing the correct amount.

본 발명의 방법에서 X가 OH인 구조식(Ⅵ) 화합물은 동일자 출원의 발명에 상세히 기재되어 있다.Structural formula (VI), wherein X is OH in the process of the invention, is described in detail in the invention of the same application.

상기와 같이 제조한 구조식(Ⅵ)화합물을 디클로로메탄, 클로로포름, 테트라하이드로퓨란, 디옥산, 벤젠과 같은 불활성 용매중에서 탄산나트륨, 탄산칼륨, 탄산수소나트륨, 탄산수소칼륨,트리에틸아민, 피리딘과 같은 산결합제 1몰 내지 4몰 당량 존재하에 포스겐, 디포스겐, 비스(트리클로로메틸)카르보네이트 바람직하기로는 비스(트리클로로메틸) 카르보네이트와 같은 카르보닐화 시약을 -50℃ 내지 50℃ 온도에서 1시간 내지 5시간 반응하여 구조식(Ⅷ)의 중간체를 생성시킨 다음 분리하지 않고 소위 원풋 반응으로 2-아미노 피리딘을 가하여 0℃ 내지 80℃에서 5시간 내지 20시간 반응시키면 목적하는 구조식(I)화합물을 높은 수율로 얻을 수 있다. 또한 구조식(VIII)로 표시되는 중간체는 구조식(Ⅵ) 화합물을 디클로로메탄, 클로로포름, 테트라하이드로퓨란, 디옥산, 벤젠과 같은 불활성 용매중에서 탄산나트륨, 탄산칼륨, 탄산수소나트륨, 탄산수소칼륨,트리에틸아민, 피리딘과 같은 산결합제 1몰 내지 4몰 당량 존재하에 티오닐클로라이드, 피발로일클로라이드, 옥살릴클로라이드 등의 할로겐화 시약을 반응시킨 후 계속해서 비스(트리클로로메틸)카르보네이트와 같은 카르보닐화 시약을 반응시킴으로서 구조식(Ⅷ) 화합물을 생성시킬 수 있으며 이와 같이 얻어진 구조식(Ⅷ) 화합물도 분리하지 않고 2-아미노피리딘과 목적하는 구조식(Ⅰ)화합물을 얻을 수 있다.The compound of formula (VI) prepared as above was prepared in an inert solvent such as dichloromethane, chloroform, tetrahydrofuran, dioxane, benzene, and acid such as sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate, triethylamine and pyridine. Carbonylation reagents such as phosgene, diphosgene, bis (trichloromethyl) carbonate, preferably bis (trichloromethyl) carbonate, in the presence of 1 to 4 molar equivalents of the binder are The reaction was carried out for 1 to 5 hours to form an intermediate of the structural formula (VII), and then without separation, 2-amino pyridine was added in a so-called one-foot reaction, followed by reaction for 5 to 20 hours at 0 ° C to 80 ° C. Can be obtained in high yield. In addition, the intermediate represented by the formula (VIII) is a compound of formula (VI) in an inert solvent such as dichloromethane, chloroform, tetrahydrofuran, dioxane, benzene, sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, triethylamine And halogenating reagents such as thionyl chloride, pivaloyl chloride and oxalyl chloride in the presence of 1 to 4 molar equivalents of an acid binder such as pyridine, followed by carbonylation such as bis (trichloromethyl) carbonate. By reacting the reagent, a structural formula compound can be produced, and 2-aminopyridine and the desired structural formula (I) compound can be obtained without separating the structural formula compound thus obtained.

이하 실시예를 들어 본 발명을 보다 상세히 설명하면 다음과 같다.Hereinafter, the present invention will be described in more detail with reference to the following examples.

참고실시예 1Reference Example 1

4-하이드록시-2-메틸-2H-1,2-벤조티아진-3-카르복실산 1,1-디옥사이드의 제조Preparation of 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxide

메틸 4-하이드록시-2-메틸-2H-1,2-벤조티아진-3-카르복실산 1,1-디옥사이드 4g을 에탄올 60ml에 혼합하고 30분간 교반한다. 여기에 수산화바륨 8수화물 8.8g을 가하고 서서히 온도를 올려 20시간 환류교반한다. 반응완료후 용매를 감압증류하여 제거하고 냉가수 100ml를 가하여 0-5℃로 냉각시킨다음 5% 염산으로 산성화(PH2)시켜 결정을 생성시킨다. 생성된 결정을 0-5℃에서 1시간 더 교반한후 여과하고 소량의 냉각수로 3회 세척한 다음 건조제로 오산화인을 사용하여 감압 건조하면 표제의 화합물 3.71g(98%)을 흰색 결정으로 얻는다.4 g of methyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxide are mixed in 60 ml of ethanol and stirred for 30 minutes. 8.8 g of barium hydroxide octahydrate was added thereto, and the temperature was gradually raised to reflux for 20 hours. After completion of the reaction, the solvent was removed by distillation under reduced pressure, 100 ml of cold water was added thereto, cooled to 0-5 ° C., and acidified with 5% hydrochloric acid (PH 2) to form a crystal. The resulting crystals were stirred for an additional hour at 0-5 ° C., filtered, washed three times with a small amount of cooling water and dried under reduced pressure using phosphorus pentoxide as a drying agent to yield 3.71 g (98%) of the title compound as white crystals. .

융점 : 140 - 143℃Melting Point: 140-143 ℃

IR(KBr,cm-1) : 3535, 3000-2200, 1660, 1340, 1170IR (KBr, cm -1 ): 3535, 3000-2200, 1660, 1340, 1170

1H-NMR(DMSO/CDCl3/TMS,δ) : 2.90(s,3H), 7.60-8.18(m,4H), 9.0(br.s,2H) 1 H-NMR (DMSO / CDCl 3 / TMS, δ): 2.90 (s, 3H), 7.60-8.18 (m, 4H), 9.0 (br.s, 2H)

원소분석 : C10H9NO5SElemental Analysis: C 10 H 9 NO 5 S

이론치 (%) : C ; 46.96, H ; 3.55, N ; 5.48Theoretical (%): C; 46.96, H; 3.55, N; 5.48

실측치 (%) : C ; 46.85, H ; 3.58, N ; 5.35Found (%): C; 46.85, H; 3.58, N; 5.35

[실시예 1]Example 1

5-메틸-3-(2-피리딜)-2H,5H-1,3-옥사지노[5,6-c]1,2-벤조티아진-2,4(3H) 디온 6,6-디옥사이드(Ⅰ)의 제조5-methyl-3- (2-pyridyl) -2H, 5H-1,3-oxazino [5,6-c] 1,2-benzothiazine-2,4 (3H) dione 6,6-dioxide Preparation of (I)

상기 참고실시예 1에서 얻은 4-하이드록시-2-메틸-2H-1,2-벤조티아진-3-카르복실산 1,1-디옥사이드(Ⅵ) 2.56g에 비스(트리클로로메틸) 카르보네이트 2.18g을 가하여 혼합하고 -15--10℃로 냉각한 다음 건조된 디클로로메탄 30ml를 가하여 10분간 교반한다. 반응액에 피리딘 1.5ml를 천천히 가한 후 온도가 상온에 도달할때까지 4시간동안 서서히 교반하고 다시 0-5℃로 냉각한다. 2-아미노피리딘 0.94g을 소량씩 나누어 가하고 온도를 서서히 올려 상온에서 18시간 교반한다. 반응용매를 감압증류하고 잔사에 메탄올과 물의 혼합용매(1 : 1)를 30ml 가하고 0-5℃에서 30분간 교반한다. 생성된 결정을 여과하고 소량의 1N-HCl, 물, 이소프로판올, 에테르의 손으로 세척하면 표제의 목적화합물(Ⅰ) 3.15g(88%)을 흰색 결정으로 얻는다.Bis (trichloromethyl) carbo to 2.56 g of 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxide (VI) obtained in Reference Example 1 above. 2.18 g of Nate were added and mixed, cooled to -15--10 ° C., and 30 ml of dried dichloromethane was added and stirred for 10 minutes. 1.5 ml of pyridine was slowly added to the reaction mixture, and the mixture was slowly stirred for 4 hours until the temperature reached room temperature, and then cooled to 0-5 ° C. 0.94 g of 2-aminopyridine is added in small portions, and the temperature is gradually increased, followed by stirring at room temperature for 18 hours. The reaction solvent was distilled under reduced pressure, 30 ml of a mixed solvent of methanol and water (1: 1) was added to the residue, followed by stirring at 0-5 ° C for 30 minutes. The resulting crystals were filtered and washed with a small amount of 1N-HCl, water, isopropanol and ether to give 3.15 g (88%) of the title compound (I) as white crystals.

융점 : 258 - 261℃Melting Point: 258-261 ℃

IR(KBr,cm-1) : 1785, 1708, 1635, 1406, 1355, 1175IR (KBr, cm -1 ): 1785, 1708, 1635, 1406, 1355, 1175

1H-NMR(DMSO/CDCl3/TMS,δ) : 3.10(s,3H), 7.58(m,2H), 8.03(m,5H), 8.63(m,1H) 1 H-NMR (DMSO / CDCl 3 / TMS, δ): 3.10 (s, 3H), 7.58 (m, 2H), 8.03 (m, 5H), 8.63 (m, 1H)

원소분석 : C16H11N3O5SElemental analysis: C 16 H 11 N 3 O 5 S

이론치 (%) : C ; 53.77, H ; 3.08, N ; 11.76Theoretical (%): C; 53.77, H; 3.08, N; 11.76

실측치 (%) : C ; 53.95, H ; 3.15, N ; 11.72Found (%): C; 53.95, H; 3.15, N; 11.72

[실시예 2]Example 2

5-메틸-3-(2-피리딜)-2H,5H-1,3-옥사지노[5,6-c]1,2-벤조티아진-2,4(3H) 디온 6,6-디옥사이드(Ⅰ)의 제조5-methyl-3- (2-pyridyl) -2H, 5H-1,3-oxazino [5,6-c] 1,2-benzothiazine-2,4 (3H) dione 6,6-dioxide Preparation of (I)

상기 참고실시예 1에서 얻은 4-하이드록시-2-메틸-2H-1,2-벤조티아진-3-카르복실산 1,1-디옥사이드(Ⅵ) 2.56g에 건조된 디클로로메탄 30ml를 가하고 계속해서 피리딘 1.5ml를 가하여 혼합한다. 반응혼합액 0-5℃로 냉각하고 티오닐 클로라이드 1ml를 주사기로 취하여 천천히 가한다음 산온에서 3시간 교반한다. 반응액이 투명해지면 비스(트리클로로메틸)카르보네이트 1.10g을 가한 후 3시간 더 교반한다. 0-5℃로 냉각하고 2-아미노 피리딘 0.94g을 소량씩 나누어 가한다음 상온에서 18시간 교반하여 반응시킨다. 반응이 완결되면 실시예 2와 같이 처리하여 표제의 목적화합물(Ⅰ) 3.04g(85%)을 흰색결정으로 얻는다.To 2.56 g of 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxide (VI) obtained in Reference Example 1, 30 ml of dried dichloromethane was added and continued. 1.5 ml of pyridine is added and mixed. The reaction mixture was cooled to 0-5 ° C., 1 ml of thionyl chloride was added through a syringe, and slowly added thereto, followed by stirring at acid temperature for 3 hours. When the reaction solution becomes clear, 1.10 g of bis (trichloromethyl) carbonate is added, followed by further stirring for 3 hours. After cooling to 0-5 ° C., 0.94 g of 2-amino pyridine was added in small portions, followed by stirring at room temperature for 18 hours. When the reaction was completed, the mixture was treated as in Example 2 to obtain 3.04 g (85%) of the title compound (I) as white crystals.

융점 : 259 - 261℃Melting Point: 259-261 ℃

IR(KBr,cm-1) : 1788, 1710, 1637, 1408, 1355, 1178IR (KBr, cm -1 ): 1788, 1710, 1637, 1408, 1355, 1178

1H-NMR(DMSO/CDCl3/TMS,δ) : 3.12(s,3H), 7.60(m,2H), 8.05(m,5H), 8.68(m,1H) 1 H-NMR (DMSO / CDCl 3 / TMS, δ): 3.12 (s, 3H), 7.60 (m, 2H), 8.05 (m, 5H), 8.68 (m, 1H)

원소분석 : C16H11N3O5SElemental analysis: C 16 H 11 N 3 O 5 S

이론치 (%) : C ; 53.77, H ; 3.08, N ; 11.76Theoretical (%): C; 53.77, H; 3.08, N; 11.76

실측치 (%) : C ; 53.70, H ; 3.18, N ; 11.80Found (%): C; 53.70, H; 3.18, N; 11.80

[실시예 3}Example 3

5-메틸-3-(2-피리딜)-2H,5H-1,3-옥사지노[5,6-c]1,2-벤조티아진-2,4(3H) 디온 6,6-디옥사이드(I)의 제조5-methyl-3- (2-pyridyl) -2H, 5H-1,3-oxazino [5,6-c] 1,2-benzothiazine-2,4 (3H) dione 6,6-dioxide Preparation of (I)

사익 참고실시예 1에서 얻은 4-하이드록시-2-메틸-2H-1,2-벤조티아진-3-카르복실산 1,1-디옥사이드(VI) 2.56g에 비스(트리클로로메틸)카르보네이트 2.18을 가하여 혼합하고 -1--10℃로 냉각한 다음 건조된 테트라하이드로퓨란 50ml를 가하여 10분간 교반한다. 반응액에 피리딘 1.5ml를 천천히 가한 후 온도가 상온에 도달할때까지 4시간동안 교반하고 다시 0-5℃로 냉각한다. 2-아미노피리딘 0.94g을 소량씩 나누어 가하고 온도를 서서히 올려 상온에서 18시간 교반한다. 반응용매를 감압 증류하고 잔사에 메탄올과 물의 혼합용매(1:1)를 30ml 가하여 0-5℃에서 30분간 교반한다. 생성된 결정을 여과하고 소량의 1H-HCl, 물, 이소프로판올, 에테르의 순으로 세척하면 표제의 목적화합물(I) 3.11g(87%)을 흰색 결정으로 얻는다.Bis (trichloromethyl) carbo to 2.56 g of 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxide (VI) obtained in Reference Example 1 Nate 2.18 is added and mixed, cooled to -1--10 ° C., and 50 ml of dried tetrahydrofuran is added and stirred for 10 minutes. 1.5 ml of pyridine was slowly added to the reaction mixture, stirred for 4 hours until the temperature reached room temperature, and cooled to 0-5 ° C. 0.94 g of 2-aminopyridine is added in small portions, and the temperature is gradually increased, followed by stirring at room temperature for 18 hours. The reaction solvent was distilled off under reduced pressure, 30 ml of a mixed solvent of methanol and water (1: 1) was added to the residue, and the mixture was stirred at 0-5 ° C for 30 minutes. The resulting crystals were filtered off and washed with a small amount of 1H-HCl, water, isopropanol, and ether in order to obtain 3.11 g (87%) of the title compound (I) as white crystals.

융점 : 258 - 261℃Melting Point: 258-261 ℃

IR(KBr,cm-1) : 1785, 1705, 1635, 1405, 1350, 1170IR (KBr, cm -1 ): 1785, 1705, 1635, 1405, 1350, 1170

1H-NMR(DMSO/CDCl3/TMS,δ) : 3.12(s,3H), 7.58(m,2H), 8.02(m,5H), 8.63(m,1H) 1 H-NMR (DMSO / CDCl 3 / TMS, δ): 3.12 (s, 3H), 7.58 (m, 2H), 8.02 (m, 5H), 8.63 (m, 1H)

원소분석 : C16H11N3O5SElemental analysis: C 16 H 11 N 3 O 5 S

이론치 (%) : C ; 53.77, H ; 3.08, N ; 11.76Theoretical (%): C; 53.77, H; 3.08, N; 11.76

실측치 (%) : C ; 53.90, H ; 3.14, N ; 11.79Found (%): C; 53.90, H; 3.14, N; 11.79

[실시예 4]Example 4

5-메틸-3-(2-피리딜)-2H,5H-1,3-옥사지노[5,6-c]1,2-벤조티아진-2,4(3H) 디온 6,6-디옥사이드(Ⅰ)의 제조5-methyl-3- (2-pyridyl) -2H, 5H-1,3-oxazino [5,6-c] 1,2-benzothiazine-2,4 (3H) dione 6,6-dioxide Preparation of (I)

상기 참고실시예 1에서 얻은 4-하이드록시-2-메틸-2H-1,2-벤조티아진-3-카르복실산 1,1-디옥사이드(Ⅵ) 2.56g에 비스(트리클로로메틸) 카르보네이트 2.18g을 가하여 혼합하고 -15--10℃로 냉각한 다음 건조된 디클로로메탄 30ml를 가하여 10분간 교반한다. 반응액에 탄산칼슘 2.8g을 천천히 가한 후 온도가 상온에 도달할때까지 6시간동안 서서히 교반하고 다시 0-5℃로 냉각한다. 2-아미노 피리딘 0.94g을 소량씩 나누어 가하고 온도를 서서히 올려 상온에서 20시간 교반한다. 반응물을 여과후 감압증류하고 잔사에 메탄올과 물의 혼합용매(1 : 1)를 30ml 가하고 0-5℃에서 1시간 교반한다. 생성된 결정을 여과하고 소량의 1N-HCl, 물, 이소프로판올, 에테르의 순으로 세척하면 표제의 목적화합물(Ⅰ) 3.97g(83%)을 흰색 결정으로 얻는다.Bis (trichloromethyl) carbo to 2.56 g of 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxide (VI) obtained in Reference Example 1 above. 2.18 g of Nate were added and mixed, cooled to -15--10 ° C., and 30 ml of dried dichloromethane was added and stirred for 10 minutes. After slowly adding 2.8 g of calcium carbonate to the reaction solution, the mixture was stirred slowly for 6 hours until the temperature reached room temperature and cooled to 0-5 ° C. 0.94 g of 2-amino pyridine is added in small portions, and the temperature is gradually raised and stirred at room temperature for 20 hours. After filtration, the reaction mixture was distilled under reduced pressure, and 30 ml of a mixed solvent of methanol and water (1: 1) was added to the residue, followed by stirring at 0-5 ° C for 1 hour. The resulting crystals were filtered and washed with a small amount of 1N-HCl, water, isopropanol and ether in order to obtain 3.97 g (83%) of the title compound (I) as white crystals.

융점 : 258 - 261℃Melting Point: 258-261 ℃

IR(KBr,cm-1):1785, 1708, 1636, 1406, 1357, 1177IR (KBr, cm -1 ): 1785, 1708, 1636, 1406, 1357, 1177

1H-NMR(DMSO/CDCl3/TMS,δ) : 3.12(s,3H), 7.60(m,2H), 8.05(m,5H), 8.65(m,1H) 1 H-NMR (DMSO / CDCl 3 / TMS, δ): 3.12 (s, 3H), 7.60 (m, 2H), 8.05 (m, 5H), 8.65 (m, 1H)

원소분석 : C16H11N3O5SElemental analysis: C 16 H 11 N 3 O 5 S

이론치 (%) : C ; 53.77, H ; 3.08, N ; 11.76Theoretical (%): C; 53.77, H; 3.08, N; 11.76

실측치 (%) : C ; 53.69, H ; 3.05, N ; 11.58Found (%): C; 53.69, H; 3.05, N; 11.58

Claims (4)

구조식(Ⅵ) 화합물에 구조식(Ⅶ)의 비스(트리할로메틸)카르보네이트를 불활성 유기용매중에서 반응시키고 계속해서 산결합제 존재하에 구조식(Ⅴ)의 2-아미노 피리딘을 반응시킴을 특징으로 하여 구조식(Ⅰ)의 목적 화합물을 제조하는 방법.The compound of formula (VI) is reacted with bis (trihalomethyl) carbonate of formula (VII) in an inert organic solvent, followed by reaction of 2-amino pyridine of formula (V) in the presence of an acid binder. A process for preparing the target compound of formula (I).
Figure kpo00007
Figure kpo00007
식중 X는 OH 또는 할로겐이며, Hal은 할로겐이다.Wherein X is OH or halogen and Hal is halogen.
제 1항에 있어서 X가 OH인 구조식(Ⅵ) 화합물에 티오닐클로라이드, 피발로일클로라이드, 옥살릴클로라이드와 같은 할로겐화 시약을 반응시킨다음 구조식(Ⅶ)의 비스(트리할로메틸)카르보네이트와 구조식 (Ⅴ)의 2-아미노피리딘을 계속해서 반응하여 구조식(Ⅰ)의 목적 화합물을 제조하는 방법.The compound of formula (VI) wherein X is OH is reacted with a halogenating reagent such as thionyl chloride, pivaloyl chloride, oxalyl chloride, and then bis (trihalomethyl) carbonate of formula (VII). And subsequently reacting 2-aminopyridine of formula (V) to produce the target compound of formula (I). 제 1항에 있어서, 불활성 용매로는 디클로로메탄, 클로로포름, 테트라하이드로퓨란, 디옥산, 벤젠, 산결합제로는 탄산나트륨, 탄산칼륨, 탄산수소나트륨, 탄산수소칼륨, 트리에틸아민, 피리딘을 사용함을 특징으로 하는 방법.The method of claim 1, wherein as an inert solvent, dichloromethane, chloroform, tetrahydrofuran, dioxane, benzene, and acid binders include sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, triethylamine, and pyridine. How to. 제1항에 있어서, 반응을 -15°내지 80℃의 온도에서 1시간 내지 24시간 반응함을 특징으로 하는 방법.The method of claim 1, wherein the reaction is carried out at a temperature of −15 ° to 80 ° C. for 1 to 24 hours.
KR1019900003775A 1990-03-21 1990-03-21 Process for the preparation of oxazino benzothiazine 6,6-dioxide derivatives KR920005746B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019900003775A KR920005746B1 (en) 1990-03-21 1990-03-21 Process for the preparation of oxazino benzothiazine 6,6-dioxide derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019900003775A KR920005746B1 (en) 1990-03-21 1990-03-21 Process for the preparation of oxazino benzothiazine 6,6-dioxide derivatives

Publications (2)

Publication Number Publication Date
KR910016763A KR910016763A (en) 1991-11-05
KR920005746B1 true KR920005746B1 (en) 1992-07-18

Family

ID=19297188

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900003775A KR920005746B1 (en) 1990-03-21 1990-03-21 Process for the preparation of oxazino benzothiazine 6,6-dioxide derivatives

Country Status (1)

Country Link
KR (1) KR920005746B1 (en)

Also Published As

Publication number Publication date
KR910016763A (en) 1991-11-05

Similar Documents

Publication Publication Date Title
SK283896B6 (en) Process for preparing sildenafil
KR850000923B1 (en) Process for preparing piroxicam
JP2000501413A (en) Method for producing 2-chlorothiazole compound
KR0130975B1 (en) Method for the preparation of herbicidal o-carboxyarylimidazolinone compounds
US5498711A (en) Synthesis of 4,10-dinitro-2,6,8,12-tetraoxa-4,10-diazatetracyclo[5.5.0.05,903,11]dodecane
KR920005746B1 (en) Process for the preparation of oxazino benzothiazine 6,6-dioxide derivatives
NO166712B (en) PROCEDURE FOR THE PREPARATION OF PYRROLIDO DERIVATIVES.
TWI771827B (en) Efficient process for making 6-carboxy benzoxazole derivatives
US4797482A (en) Process for the preparation of oxazinobenzothiazine 6,6-dioxide derivatives
JP4026233B2 (en) Method for producing 4,5-dichloro-6- (α-fluoroalkyl) pyrimidine
CA3149137A1 (en) Process and intermediates for the preparation of pyroxasulfone
KR100399854B1 (en) An Arthropodicidal Oxadiazine Intermediate
EP0146102B1 (en) Process for preparing benzothiazine compounds
RU2032679C1 (en) Derivatives of benzathiazines
KR900003501B1 (en) Process for the preparation of oxazino benzothiazine 6,6-dioxide derivatives
EP0413832A1 (en) Oxazolidinedione derivatives and production thereof
JPS6372684A (en) Manufacture of piroxicam and synthetic intermediate
KR0134906B1 (en) Intermediate compound of herbicidal
KR100209293B1 (en) New processes for preparing herbicidal pyrimidyloxybenzoic acid oxime ester derivatives
JP4047949B2 (en) Preparation of benzothiazole derivatives
KR850001223B1 (en) Process for preparing piroxicam and intermediates leading thereto
US4147876A (en) Easily hydrolyzable esters of 4-(2-carboxyethyl)phenyl trans-4-aminomethylcyclohexanecarboxylate and process of use
KR970005309B1 (en) Process for the preparation of furobenzoisoxazole derivatives
KR940010282B1 (en) Method and derivative of cyano guanidine
JP2649122B2 (en) 4,5-Dihalogeno-6- (α-substituted ethyl) pyrimidine and process for producing the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19930330

Year of fee payment: 15

LAPS Lapse due to unpaid annual fee